In addition, downregulation of HOTAIR played a vital role in enhancing the acquired resistance to imatinib via PI3K/AKT signaling in chronic myelogenous leukemia (CML) [34]. The gene discussed is PIK3CG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.